NCT03036813 2023-07-27
GBT_HOPE
Pfizer
Phase 3 Completed
Clinical Trials
3 trialsNCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
NCT01206907 2012-08-17
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
Endo Pharmaceuticals
Phase 3 Withdrawn